# OnCo record oncolytics-biotech (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/oncolytics-biotech/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "oncolytics-biotech" ;
  schema:name "Oncolytics Biotech"@en ;
  schema:description "Oncolytics Biotech is a United States-based biotechnology company running 3 late-stage cancer trials of Trifluridine Tipiracil in colorectal cancer, HR-positive / HER2-negative breast cancer and anal cancer."@en ;
  schema:url <https://onco.cc/companies/oncolytics-biotech/>, <https://www.oncolyticsbiotech.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Oncolytics_Biotech> ;
  owl:sameAs <http://www.wikidata.org/entity/Q13529450> ;
  schema:citation <https://www.oncolyticsbiotech.com>, <https://clinicaltrials.gov/search?lead=Oncolytics%20Biotech> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/anal/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:trials <https://onco.cc/trials/nct07446322/>, <https://onco.cc/trials/nct07280377/> .